Dr Reddy's Labs has announced its results for the quarter ended December 2010. It has reported consolidated net profit of Rs 273 crore as against loss of Rs 521.7 crore, as per International Financial Reporting Standards (IFRS).
The company saw extraordinary outflow of Rs 860 crore due to Betapharm in Q3FY10.
Consolidated revenues increased to Rs 1,899 crore from Rs 1,730 crore.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment